The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

Y Huang, W Hong, X Wei - Journal of hematology & oncology, 2022 - Springer
Epithelial–mesenchymal transition (EMT) is an essential process in normal embryonic
development and tissue regeneration. However, aberrant reactivation of EMT is associated …

Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compounds

HL Ang, CD Mohan, MK Shanmugam… - Medicinal research …, 2023 - Wiley Online Library
Epithelial‐mesenchymal transition (EMT) is a complex process with a primordial role in
cellular transformation whereby an epithelial cell transforms and acquires a mesenchymal …

MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases

X Wang, Y He, B Mackowiak, B Gao - Gut, 2021 - gut.bmj.com
MicroRNAs (miRNAs) are small, non-coding RNAs that post-transcriptionally regulate gene
expression by binding to specific mRNA targets and promoting their degradation and/or …

Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles

F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih… - Cell reports, 2017 - cell.com
Cholangiocarcinoma (CCA) is an aggressive malignancy of the bile ducts, with poor
prognosis and limited treatment options. Here, we describe the integrated analysis of …

Molecular mechanisms of epithelial–mesenchymal transition

S Lamouille, J Xu, R Derynck - Nature reviews Molecular cell biology, 2014 - nature.com
The transdifferentiation of epithelial cells into motile mesenchymal cells, a process known as
epithelial–mesenchymal transition (EMT), is integral in development, wound healing and …

Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets

M Klingenberg, A Matsuda, S Diederichs, T Patel - Journal of hepatology, 2017 - Elsevier
The majority of the human genome is not translated into proteins but can be transcribed into
RNA. Even though the resulting non-coding RNAs (ncRNAs) do not encode for proteins …

Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response

S Caruso, AL Calatayud, J Pilet, T La Bella, S Rekik… - Gastroenterology, 2019 - Elsevier
Background and aims Hepatocellular carcinomas (HCCs) are heterogeneous aggressive
tumors with low rates of response to treatment at advanced stages. We screened a large …

Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB

A Chow, W Zhou, L Liu, MY Fong, J Champer… - Scientific reports, 2014 - nature.com
Growing evidence links tumor progression with chronic inflammatory processes and
dysregulated activity of various immune cells. In this study, we demonstrate that various …

The regulatory role of microRNAs in EMT and cancer

A Zaravinos - Journal of oncology, 2015 - Wiley Online Library
The epithelial to mesenchymal transition (EMT) is a powerful process in tumor invasion,
metastasis, and tumorigenesis and describes the molecular reprogramming and phenotypic …

Pancreatic β cell microRNA-26a alleviates type 2 diabetes by improving peripheral insulin sensitivity and preserving β cell function

H Xu, X Du, J Xu, Y Zhang, Y Tian, G Liu, X Wang… - PLoS …, 2020 - journals.plos.org
Type 2 diabetes (T2D) is characterized by insulin resistance along with pancreatic β cell
failure. β cell factors are traditionally thought to control glucose homeostasis by modulating …